The “Pfizer Inc – Digital Transformation Strategies” report has been added to ResearchAndMarkets.com’s offering.
This report provides insight into Pfizer’s tech activities, including its digital transformation strategies, its innovation programmes, its technology initiatives, its estimated ICT budget, and its major ICT contracts.
Pfizer Inc (Pfizer) discovers, develops, manufactures, and commercializes biopharmaceuticals. The company offers products to treat various conditions such as cardiovascular, metabolic and pain, women’s health, cancer, inflammation, immune disorders, and rare diseases. It also provides sterile injectable pharmaceuticals, biosimilars, active pharmaceutical ingredients (APIs) and contract manufacturing services.
Pfizer sells its products through wholesalers, retailers, hospitals, individual provider offices, clinics, government agencies and pharmacies. It has major manufacturing facilities in India, China, Japan, Ireland, Italy, Belgium, Germany, Singapore, and the US.
The company provides its products in North America, South America, Asia-Pacific, Australia, Europe, Africa, and the Middle East. Pfizer is headquartered in New York, the US.
In January 2020, Pfizer launched its Center of Excellence Network for Vaccine Research, a global program focused on collaborating with academic institutions to conduct research on epidemiology to identify diseases that can be cured through vaccines, as well as measure its effectiveness on adults. Pfizer’s vaccine division opened its first Center of Excellence at the University of Louisville.
Pfizer Blockchain Center of Excellence through its open innovation workshop has formed an initiative called the Clinical Supply Blockchain Working Group (CSBWG) that focuses on developing an interoperable, transparent, and auditable blockchain based platform to enhance trial supply chain and experimental drug tracking.
The working group comprises of companies, such as AstraZeneca, GlaxoSmithKline, Merck, Deloitte, Biogen, LedgerDomain, and Pfizer.
Scope
Pfizer adopted AI as its core technology for conducting trials, processing vaccines, and streamlining distribution. Pfizer’s investment in digital infrastructure, digitalization of R&D operations, and AI-enabled working systems further complemented its effort in producing and distributing vaccines. Using AI technology in many phases of vaccine making and testing enabled Pfizer to roll out vaccines sooner, helping meet public’s immediate needs during initial onslaught of the global pandemic
Pfizer is adopting technologies, such as AI and analytics, for accelerating drug discovery process and to increase its efficiency. Pfizer is deploying AI technologies for streamlining its drug development. Pfizer tested a collaborative deep learning and analytics platform, dubbed Cortex, for automatic categorization of drug particle shapes. Pfizer is adopting advanced data mining techniques to glean useful insights from its existing clinical trial data, which help company discover hidden patterns, design new trials, identify new ways of utilizing existing drugs, and evaluate the effectiveness of drugs
Pfizer has rolled out various accelerator and innovation programs, including Centers of Excellence Network for Vaccine Research and Real-World Evidence; Digital Research Hubs; Pfizer Blockchain Center of Excellence; and Pfizer Innovation Research (PfIRe) Lab, to encourage start-ups, innovators, and employees. Pfizer is also involved in Project Catalyst, an external research initiative started by the AARP and other partners, including UnitedHealthcare and Georgia Tech, focusing on digital R&D to promote consumer-friendly innovation for elderly users
Key Topics Covered:
Overview
Brief information about the company, its business divisions and its financials
Digital Transformation Strategy
A summary of key digital strategies/implementation efforts of the company
Accelerators, Incubators, and Other Innovation Programs
Discusses the company’s key strategic units, innovation labs, incubation and accelerator programs dedicated to technology innovation
Technology Focus
Lists the technology themes pertinent to the industry the company operates in and highlights the themes adopted by the company
Technology Initiatives
Discussion about all the technology introductions partnerships the company has entered
Venture Arm: Pfizer Ventures
Brief information about the Company’s Ventures and its the key decision makers
Investment
Brief discussion about the investments made by the company to acquire new technologies
Acquisitions
Brief discussion about the acquisitions by the company
Partnership and Investment Network Map
A bird’s eye view of all the partnerships/investments/acquisitions that the company has made in the last 3-5 years
ICT Budget and Contracts
The company’s ICT budget segregated into hardware, software, and managed services
Key Executives
Lists key executives and Digital Transformation Executives of the company, typically the key decision makers/influencers
A selection of companies mentioned in this report includes
Tempus
Vysioneer
Gero
Anumana
Iktos
CytoReason
Saama Technologies
IBM
PostEra
Insilico Medicine
Catalia Health
Concerto HealthAI
Indegene
Adapsyn
XtalPi
Atomwise
Complexica
PointClickCare Technologies
Truveta
Prime Therapeutics
Centogene
Syapse
Flatiron Health
Foundation Medicine
Aimedis Healthcare
Chronicled
LinkLab
Seven Bridges
Adobe
AWS
Medallia
OpenEye
Oracle
Gronstedt Group
vStream
WeRobotics
Pegasystems
Fitbit
Striiv
Source: GlobalData
